| 0 |
FACTOR XIII INHIBITION |
4 |
0.1379 |
| 1 |
TRAPEZIECTOMY |
1 |
0.0909 |
| 2 |
ANTI-ERYTHROCYTE ANTIBODY POSITIVE |
2 |
0.0244 |
| 3 |
COAGULATION FACTOR XIII LEVEL DECREASED |
1 |
0.0192 |
| 4 |
INHIBITING ANTIBODIES POSITIVE |
1 |
0.0175 |
| 5 |
POSTHAEMORRHAGIC HYDROCEPHALUS |
1 |
0.0172 |
| 6 |
CIRCULATORY FAILURE NEONATAL |
1 |
0.0169 |
| 7 |
FACTOR XIII DEFICIENCY |
1 |
0.0164 |
| 8 |
MECHANICAL VENTILATION COMPLICATION |
2 |
0.0134 |
| 9 |
CHEST WALL HAEMATOMA |
3 |
0.0117 |
| 10 |
RECTAL ULCER HAEMORRHAGE |
2 |
0.0080 |
| 11 |
COAGULATION FACTOR DECREASED |
2 |
0.0073 |
| 12 |
INSPIRATORY CAPACITY DECREASED |
2 |
0.0072 |
| 13 |
AIRWAY PEAK PRESSURE INCREASED |
1 |
0.0066 |
| 14 |
ANGIODYSPLASIA |
2 |
0.0055 |
| 15 |
PLACENTA ACCRETA |
1 |
0.0046 |
| 16 |
RETINOPATHY OF PREMATURITY |
2 |
0.0036 |
| 17 |
STEROID THERAPY |
1 |
0.0035 |
| 18 |
ROTAVIRUS INFECTION |
2 |
0.0035 |
| 19 |
COMPLICATION OF DELIVERY |
1 |
0.0035 |
| 20 |
CENTRAL VENOUS CATHETER REMOVAL |
1 |
0.0021 |
| 21 |
EAR INJURY |
1 |
0.0020 |
| 22 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 23 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
2 |
0.0016 |
| 24 |
BRONCHOPULMONARY DYSPLASIA |
1 |
0.0012 |
| 25 |
INTRAVENTRICULAR HAEMORRHAGE |
3 |
0.0012 |
| 26 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
0.0011 |
| 27 |
BICYTOPENIA |
2 |
0.0010 |
| 28 |
HENOCH-SCHONLEIN PURPURA |
2 |
0.0009 |
| 29 |
INFECTED CYST |
1 |
0.0008 |
| 30 |
NECROTISING COLITIS |
1 |
0.0008 |
| 31 |
APPENDIX DISORDER |
1 |
0.0007 |
| 32 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 33 |
HAEMOTHORAX |
2 |
0.0007 |
| 34 |
HEPATITIS B |
4 |
0.0007 |
| 35 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 36 |
VENOUS OCCLUSION |
1 |
0.0005 |
| 37 |
SHOCK HAEMORRHAGIC |
4 |
0.0005 |
| 38 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 39 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0004 |
| 40 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 41 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 42 |
HERNIA REPAIR |
1 |
0.0004 |
| 43 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 44 |
ANGIOPATHY |
2 |
0.0004 |
| 45 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 46 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 47 |
HYPOVOLAEMIA |
2 |
0.0003 |
| 48 |
NECK INJURY |
1 |
0.0003 |
| 49 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 50 |
DISSEMINATED INTRAVASCULAR COAGULATION |
4 |
0.0003 |
| 51 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 52 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 53 |
BODY TEMPERATURE DECREASED |
2 |
0.0002 |
| 54 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 55 |
EMPHYSEMA |
2 |
0.0002 |
| 56 |
DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0002 |
| 57 |
REBOUND EFFECT |
2 |
0.0002 |
| 58 |
ADVERSE REACTION |
2 |
0.0002 |
| 59 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 60 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 61 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 62 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 63 |
FOOD ALLERGY |
1 |
0.0001 |
| 64 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 65 |
PNEUMOTHORAX |
2 |
0.0001 |
| 66 |
BLOOD DISORDER |
1 |
0.0001 |
| 67 |
EPISTAXIS |
9 |
0.0001 |
| 68 |
FACE OEDEMA |
2 |
0.0001 |
| 69 |
HAEMATOMA |
3 |
0.0001 |
| 70 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 71 |
HAEMARTHROSIS |
1 |
0.0001 |
| 72 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 73 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 74 |
THERAPY CHANGE |
1 |
0.0001 |
| 75 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 76 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 77 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 78 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 79 |
HEAD INJURY |
3 |
0.0001 |
| 80 |
SKIN LACERATION |
1 |
0.0001 |
| 81 |
DENTAL CARIES |
1 |
0.0001 |
| 82 |
HAEMATURIA |
3 |
0.0001 |
| 83 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 84 |
HAEMORRHAGE |
9 |
0.0001 |
| 85 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 86 |
TOOTH INFECTION |
1 |
0.0001 |
| 87 |
BRONCHOSPASM |
1 |
0.0001 |
| 88 |
APATHY |
1 |
0.0001 |
| 89 |
INSURANCE ISSUE |
1 |
0.0001 |
| 90 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 91 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 92 |
BACK DISORDER |
1 |
0.0001 |
| 93 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 94 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 95 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 96 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 97 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 98 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 99 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 100 |
MENORRHAGIA |
1 |
0.0001 |
| 101 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 102 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 103 |
SHOCK |
1 |
0.0000 |
| 104 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 105 |
NO ADVERSE EVENT |
7 |
0.0000 |
| 106 |
DEAFNESS |
1 |
0.0000 |
| 107 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 108 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 109 |
FLATULENCE |
2 |
0.0000 |
| 110 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 111 |
VIRAL INFECTION |
1 |
0.0000 |
| 112 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 113 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 114 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 115 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 116 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 117 |
SEPTIC SHOCK |
1 |
0.0000 |
| 118 |
TACHYCARDIA |
2 |
0.0000 |
| 119 |
DEVICE ISSUE |
2 |
0.0000 |
| 120 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 121 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 122 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 123 |
RENAL DISORDER |
1 |
0.0000 |
| 124 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 125 |
HEART RATE INCREASED |
2 |
0.0000 |
| 126 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 127 |
NERVOUSNESS |
1 |
0.0000 |
| 128 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 129 |
SEIZURE |
2 |
0.0000 |
| 130 |
SURGERY |
1 |
0.0000 |
| 131 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 132 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 133 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 134 |
HYPOTENSION |
3 |
0.0000 |
| 135 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 136 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 137 |
URTICARIA |
2 |
0.0000 |
| 138 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 139 |
CONTUSION |
1 |
0.0000 |
| 140 |
FLUSHING |
1 |
0.0000 |
| 141 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 142 |
CONSTIPATION |
2 |
0.0000 |
| 143 |
OFF LABEL USE |
8 |
0.0000 |
| 144 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 145 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 146 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 147 |
BACK PAIN |
2 |
0.0000 |
| 148 |
WEIGHT DECREASED |
2 |
0.0000 |
| 149 |
INFECTION |
1 |
0.0000 |
| 150 |
HOSPITALISATION |
1 |
0.0000 |
| 151 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 152 |
PYREXIA |
2 |
0.0000 |
| 153 |
MUSCLE SPASMS |
1 |
0.0000 |
| 154 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 155 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 156 |
HYPERTENSION |
1 |
0.0000 |
| 157 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 158 |
VOMITING |
2 |
0.0000 |
| 159 |
DYSPNOEA |
2 |
0.0000 |
| 160 |
ANXIETY |
1 |
0.0000 |
| 161 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 162 |
PAIN |
2 |
0.0000 |
| 163 |
PNEUMONIA |
1 |
0.0000 |
| 164 |
FALL |
1 |
0.0000 |
| 165 |
ASTHENIA |
1 |
0.0000 |
| 166 |
FATIGUE |
2 |
0.0000 |
| 167 |
ARTHRALGIA |
1 |
0.0000 |
| 168 |
MALAISE |
1 |
0.0000 |
| 169 |
HEADACHE |
1 |
0.0000 |
| 170 |
NAUSEA |
1 |
0.0000 |